Mineral and Bone Disorder-New EXecute Trial

Mineral and Bone Disorder-New EXecute Trial - MBD-NEXT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039961

Enrollment

8400

Registered

2020-04-01

Start date

2019-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperphosphatemia under maintenance hemodialysis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Maintenance hemodialysis patients who fulfill the following conditions 1) Patients who have given written informed consent 2) Patients with serum phosphate level of 3.5mg / dL or more or taking any phoshate binders.

Exclusion criteria

Exclusion criteria: Non

Design outcomes

Primary

Measure	Time frame
Mortality, cardiovascular mortality, hospitatization, lower limb intervention, anemia, vascular access, etc.	—

Secondary

Measure	Time frame
Laboratory data and PROs (patient reported outcomes)	—

Countries

Japan

Contacts

Public ContactHiroshi Kirayama

JAPAN CONVENTION SERVICES,INC Medical Department

h-kira@convention.co.jp03-3508-1214

Outcome results